Pneumocystis pneumonia and disseminated toxoplasmosis in a male homosexual
Within the past two years 788 cases of the apparently new and potentially lethal syndrome of acquired immune deficiency have been reported in the United States.' Only three cases have been reported in the United Kingdom.2-4 We report a case in a previously healthy 37 year old male homosexual who was initially diagnosed and treated for pneumocystis pneumonia and subsequently died of widespread toxoplasmosis.
Case report
The patient presented with an eight week history of malaise, non-productive cough, night sweats, diarrhoea, anorexia, and weight loss. He had previously acquired syphilis, hepatitis B, and on four occasions gonorrhoea. His recreational drugs were amyl nitrite and lysergide. His male partner was apparently well.
Pneumocystis pneumonia was suspected in view of his history, and bilateral patchy shadowing was seen on chest x ray films. He had no lymphadenopathy. Initial investigations showed haemoglobin 9.5 g/dl and white cell count 4-9 x 109/l (neutrophils 89,o, lymphocytes 40%, monocytes 5%, eosinophils 2%). Lactate dehydrogenase activity was greater than 800 IU/I. Serum albumin concentration was 27 g/l and serum immunoglobulins were in the normal range except for a slightly raised concentration of IgG to 14-6 g/l. Transbronchial biopsy failed to show Pneumocystis carinii. Treatment was started with intravenous co-trimoxazole (240 mg trimethoprim and 1200 mg sulphamethoxazole twice daily). The pneumocystis immunofluorescent antibody titre rose from 1/16 on admission to 1/128 three weeks later. After 48 hours the co-trimoxazole regimen was altered to 160 mg trimethoprim and 800 mg sulphamethoxazole by mouth six times a day. There was no serological evidence of infection with cytomegalovirus. No virus was isolated from stool, cerebrospinal fluid, blood, urine, or throat. The toxoplasma dye test titre was 1/128. Apart from detecting a negative Mantoux response, we were unable to study delayed hypersensitivity reactions.
After 13 days' treatment, despite some clinical improvement, his temperature remained raised and intravenous co-trimoxazole was given for a further 15 days (400 mg trimethoprim and 2000 mg sulphamethoxazole twice a day). Serum concentrations of trimethoprim were above 5 mg/l. Three weeks later his symptoms recurred and chest x ray films again showed abnormalities, so pentamidine isethionate was given (in a dose of 200 mg intramuscularly once a day increasing to 250 mg after two days). After six days' treatment severe pyrexia developed (40 5°C) and he became delirious, hypotensive (blood pressure 80/50 mm Hg), and hypovolaemic. The drug was stopped because of possible toxicity, and despite correction of the fluid deficit he died suddenly the next day.
Necropsy was performed two days after death, and histological examination of the brain, pituitary, myocardium, liver, lungs, and trachea showed large numbers of tissue cysts of Toxoplasma gondii with myocarditis and encephalitis. There was no evidence of Pneumocystis carinii, Kaposi's sarcoma, or lymphoma. The toxoplasma serology on stored sera was then reviewed. On admission the toxoplasma dye test titre had been 1/128; six weeks later it had not changed appreciably (1/256), but a week before death the titre had risen to 1/2056. Toxoplasma specific IgM could not be detected in any sample.
Comment
The diagnosis of pneumocystis pneumonia in our patient was based on a rising antibody titre. Transbronchial biopsy techniques are less reliable than open lung biopsy, and this may have accounted for our failure to detect the organism.
There was unequivocal histological evidence of disseminated toxoplasmosis at necropsy despite the lack of toxoplasma specific IgM in the serum. While conventional treatment for toxoplasmosis is with pyrimethamine and a sulphonamide, co-trimoxazole is an alternative agent. It is thus possible that the treatment directed at the pneumocystis pneumonia may have diminished the immune response to toxoplasmosis by coincidentally treating the latter, albeit ineffectively.
The diagnosis of opportunistic infections in patients with the acquired immune deficiency syndrome is complex: infections may be multiple, invasive techniques may be required, and serological or histological evidence of infection may be absent. In the management of a patient with the syndrome the doctor must be constantly aware of the possibility of further infections developing. The high mortality rate of the syndrome (>60% for cases diagnosed before June 1981)6 surely justifies the use of invasive techniques for diagnosis.
We thank Professor W I Cranston for permission to report his patient, Dr I E West and Dr H Pambakian, who reported the histology, for helpful discussions, and Dr B Jameson and Dr D G Fleck for their valuable assistance with the pneumocystis and toxoplasma serology. Finger sepsis: possible complication of self monitoring of blood glucose concentrations Self monitoring of blood glucose concentrations has greatly facilitated the achievement of improved glycaemic control in diabetics.' Capillary blood samples are usually obtained by pricking a finger with a small stylet, and except for some coarsening of the skin' the procedure has been remarkably free of complications.2 We report two cases in which a more serious complication occurred. 
